Movetis Receives Positive Opinion by the CHMP on European Marketing Authorisation Application for Resolor(R) (prucalopride) Indicated for the Treatment of Chronic Constipation
TURNHOUT, Belgium, July 27 /PRNewswire/ -- Movetis, the GI specialty pharmaceutical company based in Belgium announces today that it has received a positive opinion from the Committee for Medicinal…